English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Pseudin-2 is a cationic α-helical peptide that was first isolated from the skin of the paradoxical frog  Pseudis paradoxa  on the basis of its antimicrobial activity. We have investigated the insulin-releasing properties and cytotoxicity of the peptide, together with selected analogues with increased cationicity and hydrophobicity. At concentrations in the range 10 -9 –10 -6   m , pseudin-2, and its [Lys 18 ], [Phe 8 ], and [ d -Lys 3 , d -Lys 10 , d -Lys 14 ] derivatives, stimulated insulin release from the BRIN-BD11 clonal β-cell line without increasing release of lactate dehydrogenase. The [Lys 18 ] analogue was the most potent (46% increase in insulin release at 10 -9   m ) and the most effective (215% increase in insulin release at 10 -6   m ). The more cationic [Lys 3 ,Lys 10 ,Lys 14 ] and [Lys 3 ,Lys 10 ,Lys 14 ,Lys 21 ] analogues lacked insulinotropic action and the more hydrophobic [Phe 16 ] analogue was cytotoxic at concentrations ≥10 -7   m . Pseudin-2 and [Lys 18 ]-pseudin-2 had no effect on intracellular calcium concentrations and stimulated insulin release in the absence of external calcium. [Lys 18 ]-pseudin-2 (10 -8   m ) stimulated insulin release in the presence of diazoxide and verapamil. Our results demonstrate that pseudin-2 stimulates insulin secretion from BRIN-BD11 cells by a mechanism involving Ca 2+ -independent pathways and identify [Lys 18 ]-pseudin-2 as a peptide that may have potential for development as a therapeutically valuable insulinotropic agent for the treatment of type 2 diabetes.

Insulin-releasing properties of the frog skin peptide pseudin-2 and its [Lys 18 ]-substituted analogue